AIOT underwent a massive business transformation with revenue growing 974% to $362.5M, but this growth came with proportionally higher losses and a significant debt increase to $237.5M.
The dramatic scale increase across all financial metrics suggests AIOT completed a major acquisition or merger during this period, fundamentally changing the company's size and scope. While revenue growth of nearly 1000% appears positive, the fact that net losses deepened significantly (from -$8.5M to -$51.0M) indicates the acquired operations are not yet profitable and integration challenges may exist.
AIOT experienced explosive growth with revenue increasing 974% to $362.5M and gross profit growing 1100% to $194.5M, but this came at the cost of dramatically higher operating expenses (SG&A up 836%, R&D up 696%) and a six-fold increase in net losses to -$51.0M. The company's debt load surged 1384% to $237.5M while stockholders' equity grew 1059% to $446.6M, and capital expenditures jumped to $20.0M with operating cash flow deteriorating to -$3.3M. This financial profile suggests a transformative acquisition that significantly expanded the business but created near-term profitability and cash flow challenges that investors should monitor closely.
Share repurchases increased 9048.4% — management returning capital, signals confidence in intrinsic value.
Operating cash flow fell 1508.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Capital expenditure jumped 1428.5% — major investment cycle underway; assess returns on deployment.
Debt increased 1383.9% — substantial leverage increase; assess whether deployed for growth or covering losses.
Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.
Equity base grew 1059% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Strong top-line growth of 974.4% — accelerating demand or successful expansion into new markets.
SG&A up 836.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.
R&D investment increased 695.9% — signals commitment to future product development, though near-term margin impact.
Net income declined 498.8% — review whether driven by operations, interest costs, or non-recurring items.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →